kentucky semaglutide pancreatitis legal team glp-1 nausea in kentucky nausea law office Infectious Diseases glp-1 law firm in kentucky glp-1 pancreatitis attorney in

Whilst this might seem desirable, excessively rapid weight loss (generally defined as more than 0.51 kg per week after the initial period) can be associated with gallstone formation, muscle loss, and nutritional deficiencies

Disclaimer: These experiences are individual and not intended to imply typical results

Weight loss injections represent a class of medications that include glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Wegovy) and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists such as tirzepatide (Zepbound)

In addition, many patients are actually overtraining and may be making it more difficult to lose weight